107 related articles for article (PubMed ID: 12629864)
1. Intestinal necrosis following Calcium Resonium-sorbitol administration in a premature uraemic infant.
Chlumská A; Boudová L; Pavlovský M; Sulc M
Cesk Patol; 2002 Oct; 38(4):169-72. PubMed ID: 12629864
[TBL] [Abstract][Full Text] [Related]
2. Cecal perforation associated with sodium polystyrene sulfonate-sorbitol enemas in a 650 gram infant with hyperkalemia.
Bennett LN; Myers TF; Lambert GH
Am J Perinatol; 1996 Apr; 13(3):167-70. PubMed ID: 8688109
[TBL] [Abstract][Full Text] [Related]
3. Kayexalate (sodium polystyrene sulphonate) in sorbitol associated with intestinal necrosis in uremic patients.
Gardiner GW
Can J Gastroenterol; 1997 Oct; 11(7):573-7. PubMed ID: 9395757
[TBL] [Abstract][Full Text] [Related]
4. Intestinal Necrosis Associated with Orally Administered Calcium Polystyrene Sulfonate Without Sorbitol.
Goutorbe P; Montcriol A; Lacroix G; Bordes J; Meaudre E; Souraud JB
Ann Pharmacother; 2011 Feb; 45(2):e13. PubMed ID: 21304040
[TBL] [Abstract][Full Text] [Related]
5. Necrosis of the gastrointestinal tract in uremic patients as a result of sodium polystyrene sulfonate (Kayexalate) in sorbitol: an underrecognized condition.
Rashid A; Hamilton SR
Am J Surg Pathol; 1997 Jan; 21(1):60-9. PubMed ID: 8990142
[TBL] [Abstract][Full Text] [Related]
6. Intestinal necrosis due to sodium polystyrene (Kayexalate) in sorbitol enemas: clinical and experimental support for the hypothesis.
Lillemoe KD; Romolo JL; Hamilton SR; Pennington LR; Burdick JF; Williams GM
Surgery; 1987 Mar; 101(3):267-72. PubMed ID: 3824154
[TBL] [Abstract][Full Text] [Related]
7. [Polystyrene sodium sulfonate enema: with or without sorbitol?].
Marion F; Joye F
Presse Med; 1999 Feb; 28(7):338. PubMed ID: 10083877
[No Abstract] [Full Text] [Related]
8. Hematochezia associated with the use of hypertonic sodium polystyrene sulfonate enemas in premature infants.
Milley JR; Jung AL
J Perinatol; 1995; 15(2):139-42. PubMed ID: 7595773
[TBL] [Abstract][Full Text] [Related]
9. Ileum and colon perforation following peritoneal dialysis-related peritonitis and high-dose calcium polystyrene sulfonate.
Kao CC; Tsai YC; Chiang WC; Mao TL; Kao TW
J Formos Med Assoc; 2015 Oct; 114(10):1008-10. PubMed ID: 23602017
[TBL] [Abstract][Full Text] [Related]
10. Ileocolic perforation secondary to sodium polystyrene sulfonate in sorbitol use: a case report.
Trottier V; Drolet S; Morcos MW
Can J Gastroenterol; 2009 Oct; 23(10):689-90. PubMed ID: 19826644
[TBL] [Abstract][Full Text] [Related]
11. Colitis induced by sodium polystyrene sulfonate in sorbitol: A report of six cases.
Jacob SS; Parameswaran A; Parameswaran SA; Dhus U
Indian J Gastroenterol; 2016 Mar; 35(2):139-42. PubMed ID: 27033844
[TBL] [Abstract][Full Text] [Related]
12. Acute abdomen with colonic necrosis induced by Kayexalate-sorbitol.
Dardik A; Moesinger RC; Efron G; Barbul A; Harrison MG
South Med J; 2000 May; 93(5):511-3. PubMed ID: 10832954
[TBL] [Abstract][Full Text] [Related]
13. Association of prescription of oral sodium polystyrene sulfonate with sorbitol in an inpatient setting with colonic necrosis: a retrospective cohort study.
Watson MA; Baker TP; Nguyen A; Sebastianelli ME; Stewart HL; Oliver DK; Abbott KC; Yuan CM
Am J Kidney Dis; 2012 Sep; 60(3):409-16. PubMed ID: 22683337
[TBL] [Abstract][Full Text] [Related]
14. Colonic necrosis and perforation following oral sodium polystyrene sulfonate (Resonium A/Kayexalate in a burn patient.
Cheng ES; Stringer KM; Pegg SP
Burns; 2002 Mar; 28(2):189-90. PubMed ID: 11900946
[No Abstract] [Full Text] [Related]
15. Colonic necrosis in a young patient receiving oral kayexalate in sorbitol: case report and literature review.
Chou YH; Wang HY; Hsieh MS
Kaohsiung J Med Sci; 2011 Apr; 27(4):155-8. PubMed ID: 21463839
[TBL] [Abstract][Full Text] [Related]
16. Benefits and risks of calcium resonium therapy in hyperkalaemic preterm infants.
Grammatikopoulos T; Greenough A; Pallidis C; Davenport M
Acta Paediatr; 2003; 92(1):118-20. PubMed ID: 12650312
[TBL] [Abstract][Full Text] [Related]
17. Colonic mucosal necrosis following administration of calcium polystryrene sulfonate (Kalimate) in a uremic patient.
Joo M; Bae WK; Kim NH; Han SR
J Korean Med Sci; 2009 Dec; 24(6):1207-11. PubMed ID: 19949685
[TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal adverse events with sodium polystyrene sulfonate (Kayexalate) use: a systematic review.
Harel Z; Harel S; Shah PS; Wald R; Perl J; Bell CM
Am J Med; 2013 Mar; 126(3):264.e9-24. PubMed ID: 23321430
[TBL] [Abstract][Full Text] [Related]
19. Constipation and colonic perforation complicating calcium resonium therapy.
Minford EJ; Hand T; Jones MC
Postgrad Med J; 1992 Apr; 68(798):302. PubMed ID: 1409204
[No Abstract] [Full Text] [Related]
20. Intestinal necrosis associated with postoperative orally administered sodium polystyrene sulfonate in sorbitol.
Gerstman BB; Kirkman R; Platt R
Am J Kidney Dis; 1992 Aug; 20(2):159-61. PubMed ID: 1496969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
